CLINICAL NEWS

3 studies find aspirin reduces risk of cancer deaths, metastasis

Aspirin can reduce the risk for cancer-related mortality and can reduce or prevent the risk for distant metastasis, according to 3 new studies published online by The Lancet and The Lancet Oncology. » More

Antioxidants may not benefit patients with Alzheimer’s disease

Daily supplementation with antioxidants, vitamins E and C, and alpha acid, did not improve memory function in patients with Alzheimer’s disease, according to a new study. » More

Editor's Pick

FDA user fee renewal addresses drug shortages, new drug development

Every 5 years, Congress is called on to reauthorize a series of user fees that support FDA oversight of drugs and medical products. The Prescription Drug User Fee Act and similar measures authorize fees to fund a number of FDA regulatory programs. This must-pass bill, however, creates a ready legislative vehicle for policy-makers to add on a host of pet FDA-related measures. » Click here.

CONTINUING EDUCATION

The latest FDA drug approvals: What you need to know

Of the 35 new molecular entities approved by FDA in 2011, 17 are considered groundbreaking because of their potential to make a real difference in the lives of patients.

To read and print the article with TEST QUESTIONS, click here. To proceed to the online exams and earn up to 2 CPE credits, click here to login.

PATIENT CARE

Enhanced pharmacist care improves LDL in patients with dyslipidemia

Enhanced pharmacist care for patients with dyslipidemia improves low-density lipoprotein cholesterol levels, according to a study published in the March issue of Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy. » More

ADHERENCE

Study: Texting enhances HIV therapy compliance

Weekly mobile phone text messaging may help patients with human immunodeficiency virus adhere to antiretroviral therapy that is often associated with difficult side effects, according to a study published online March 14 in the Cochrane Database of Systematic Reviews. » More

FDA News

FDA approves 'dry' nasal aerosol to treat allergy symptoms

FDA has approved beclomethasone dipropionate (QNASL Nasal Aerosol, Teva Pharmaceutical Industries), a “dry” nasal aerosol corticosteroid that treats year-round and seasonal nasal allergy symptoms in people aged 12 years and older. » More

FDA issues CRL for orally inhaled migraine treatment

FDA has issued a complete response letter to dihydroergotamine (Levadex inhalation aerosol, MAP Pharmaceuticals) for the treatment of acute treatment of migraine in adults.
» More

Survey

In the online New England Journal of Medicine, 2 Canadian doctors disagree with Medicare's 3-year coverage policy of immunosuppressive therapy following kidney transplantation because the annual cost of immunosuppressive therapy is $15,000 to $20,000 but the cost of dialysis after graft failure is substantially higher at $75,000. Should Medicare change its policy of 3-year coverage of immunosuppressive therapy following kidney transplantation to lifelong coverage?

Yes
No

Respond here and see what your colleagues think too.

Want to see the results of our last survey regarding who performs medication therapy management in your health system? Click here.

Confirm your
e-newsletter subscription click here.

To ensure future delivery of email newsletters from Formulary please take a moment to confirm your subscription by clicking here.
Thank you,
Formulary Staff

Resources

Digital Edition